CF Industries Holdings, Inc. (New York Stock Exchange:CF)
| Market Cap | 18.66B+48.9% |
| Revenue (ttm) | 7.74B+20.0% |
| Net Income | 2.10B+61.2% |
| EPS | 13.49+76.1% |
| Shares Out | 151.34M |
| PE Ratio | 9.12 |
| Forward PE | 10.57 |
| Dividend | $2.10(1.70%) |
| Ex-Dividend Date | Nov 16, 2026 |
| Volume | 1,659,358 |
| Open | 118.97 |
| Previous Close | 118.09 |
| Day's Range | 118.40 - 123.53 |
| 52-Week Range | 75.42 - 141.96 |
| Beta | 0.40 |
| Analysts | Buy |
| Price Target | 127.86(+3.70%) |
| Earnings Date | Nov 4, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About CF
CF Industries Holdings, Inc. is a global producer and distributor of hydrogen and nitrogen-based products. These essential chemicals serve a variety of purposes worldwide, including energy generation, agricultural fertilization, environmental emissions reduction, and numerous other industrial applications. The company's core product lineup features vital nitrogen compounds such as anhydrous ammonia, granular urea, urea ammonium nitrate (UAN), and different forms of ammonium nitrate. In addition to these primary offerings, CF Industries also provides specialized chemicals like diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia, alongside complex fertilizers containing nitrogen, phosphorus, and potassium. Its diverse customer base includes agricultural cooperatives, independent fertilizer distributors, commodity traders, wholesalers, and a wide array of industrial end-users. Founded in 1946, the firm is headquartered in Deerfield, Illinois.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
4 firms rating CF in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 4, 2026Earnings report
- Nov 16, 2026Ex-dividend date
Ask Barron about CF
$CF stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CF by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 27, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 9, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 9, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 8, 2026 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Apr 29, 2020 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Apr 29, 2020 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Apr 28, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 18, 2020 |
Recently reported changes in CF holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CF's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CF Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CF Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CF patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CF from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CF
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $552.92M |
| VOOVanguard S&P 500 ETF | $457.90M |
| VBVanguard Morningstar Small-Cap ETF | $392.41M |
| VBRVanguard Morningstar Small-Cap Value ETF | $255.40M |
| IVViShares Core S&P 500 ETF | $237.90M |
| XLBState Street Materials Select Sector SPDR ETF | $223.51M |
Estimated from each fund’s disclosed top holdings × AUM
CF Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CF’s recent data — informational, not investment advice
What’s Behind the Score
News check: Mixed analyst actions on price targets; UBS upgraded PT and notes improving nitrogen outlook, but KeyBanc and BofA cut targets with neutral/underperform ratings.